Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia

Nat Commun. 2019 Mar 21;10(1):1322. doi: 10.1038/s41467-019-09160-7.

Abstract

Heparin-induced thrombocytopenia/thrombosis (HIT) is a serious immune reaction to heparins, characterized by thrombocytopenia and often severe thrombosis with high morbidity and mortality. HIT is mediated by IgG antibodies against heparin/platelet factor 4 antigenic complexes. These complexes are thought to activate platelets leading to thrombocytopenia and thrombosis. Here we show that HIT immune complexes induce NETosis via interaction with FcγRIIa on neutrophils and through neutrophil-platelet association. HIT immune complexes induce formation of thrombi containing neutrophils, extracellular DNA, citrullinated histone H3 and platelets in a microfluidics system and in vivo, while neutrophil depletion abolishes thrombus formation. Absence of PAD4 or PAD4 inhibition with GSK484 abrogates thrombus formation but not thrombocytopenia, suggesting they are induced by separate mechanisms. NETs markers and neutrophils undergoing NETosis are present in HIT patients. Our findings demonstrating the involvement of NETosis in thrombosis will modify the current concept of HIT pathogenesis and may lead to new therapeutic strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen-Antibody Complex / biosynthesis
  • Blood Platelets / drug effects
  • Blood Platelets / immunology*
  • Citrullination
  • Enzyme Inhibitors / pharmacology
  • Extracellular Traps / chemistry
  • Extracellular Traps / drug effects
  • Extracellular Traps / immunology*
  • Gene Expression Regulation
  • Heparin / adverse effects*
  • Histones / genetics
  • Histones / immunology
  • Humans
  • Immunoglobulin G / biosynthesis
  • Mice
  • Mice, Transgenic
  • Microfluidic Analytical Techniques
  • Neutrophil Activation / drug effects
  • Neutrophil Activation / immunology
  • Neutrophils / drug effects
  • Neutrophils / immunology*
  • Platelet Activation / drug effects
  • Platelet Activation / immunology
  • Platelet Factor 4 / genetics
  • Platelet Factor 4 / immunology
  • Protein-Arginine Deiminase Type 4
  • Protein-Arginine Deiminases / antagonists & inhibitors
  • Protein-Arginine Deiminases / genetics
  • Protein-Arginine Deiminases / immunology
  • Receptors, IgG / genetics*
  • Receptors, IgG / immunology
  • Signal Transduction
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / immunology*
  • Thrombocytopenia / pathology
  • Thrombosis / chemically induced
  • Thrombosis / immunology*
  • Thrombosis / pathology
  • Thrombosis / prevention & control

Substances

  • Antigen-Antibody Complex
  • Enzyme Inhibitors
  • Fc gamma receptor IIA
  • Histones
  • Immunoglobulin G
  • PF4 protein, human
  • Receptors, IgG
  • Platelet Factor 4
  • Heparin
  • PADI4 protein, human
  • Protein-Arginine Deiminase Type 4
  • Protein-Arginine Deiminases
  • peptidylarginine deiminase 4, mouse